Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- kits assays EIAs ELISAs enzymes immunoassays LH lutein hormones glycoproteins pituitary glands alpha-subunits .alpha.-subunits ?-subunits beta-subunits .beta.-subunits ?-subunits follicle stimulating FSH thyroid stimulating TSH chorionic gonadotropin hCG ovulation corpus luteum pregnancy testosterone testis biomarker homeostasis fertility regulation hypothalmic-pituitary-gonadal axis immunometric sandwich human serums
- Product Overview:
Luteinizing hormone (LH) is a glycoprotein produced by the pituitary gland and consists of two subunits with a total molecular mass of approximately 30 kDa. The ?-subunit is identical to the ?-subunit of other pituitary hormones, such follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), and chorionic gonadotropin (hCG). The ?-subunit is unique to LH and confers the specific biological activity to the molecule. Luteinizing hormone stimulates ovulation and the development of the corpus luteum, and maintains the function of the corpus luteum during the first two weeks of pregnancy. In males, LH stimulates the production of testosterone by the testis. Cayman’s Luteinizing Hormone ELISA (human) Kit is an immunometric (i.e., sandwich) ELISA which can be used to measure luteinizing hormone within the range of 0.5-200 mIU/ml. This assay offers specific and sensitive analysis of LH in human serum and has not been validated for other types of samples.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.